Sara Bonstein
CIK 1604019 · Chief Financial Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.76M
Companies
6
Total Filings
105
Lifetime Open-Market Net
-$44.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INSM | Chief Financial Officer | 69,082 | $97.85 | $6.76M | -$44.19M | 33 | 2026-06-05 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 7 | 2025-10-07 |
| XLO | Director | — | $8.31 | — | $0 | 4 | 2025-06-12 |
| ONCOSEC MEDICAL Inc (ONCS) Delisted | CFO/COO | 41,389 | $0.28 | $11.5K | -$5.0K | 8 | 2020-01-21 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Chief Financial Officer | 226,670 | — | — | -$110.7K | 21 | 2018-04-03 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Financial Officer | 81,577 | — | — | -$83.9K | 32 | 2016-10-04 |
Recent Filings · Page 6 of 11
105 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-18 | ONCOSEC MEDICAL Inc (ONCS) Delisted | Tax (F) | −15,405 | -$24.3K | EDGAR |
| 2018-07-18 | ONCOSEC MEDICAL Inc (ONCS) Delisted | Mixed | +489,515 | -$181.5K | EDGAR |
| 2018-04-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +1,088 | $1.8K | EDGAR |
| 2018-03-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +989 | $1.8K | EDGAR |
| 2018-02-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | −580 | -$1.7K | EDGAR |
| 2018-01-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −4,751 | -$15.3K | EDGAR |
| 2017-12-04 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +856 | $2.6K | EDGAR |
| 2017-11-06 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −3,862 | -$12.7K | EDGAR |
| 2017-11-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −12,355 | -$39.3K | EDGAR |
| 2017-10-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +423 | $1.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.